Over 2.5 million users have downloaded ChemSketch Freeware, the academic chemical drawing software from ACD/Labs Toronto, CANADA — ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, today announced that ChemSketch Freeware has been downloaded by over 2.5 million users worldwide. This free version of ChemSketch, intended for academic and personal use, […]
— Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical, and biotechnology industries and academia — Seamless integration within Revvity Signals Research platform empowers multidisciplinary discoveries WALTHAM, Mass. — Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw® offering, the latest advancement in the Revvity Signals Software portfolio. […]
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the launch of Semeta™, a metabolism prediction platform tailored specifically for drug metabolism […]
Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery process. The newly announced collaboration involves the development of groundbreaking technology to enable the […]
Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery Cambridge, UK, 11: DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the launch of its Early Access Programme after a successful closed beta programme during […]
AIDDISON™ software-as-a-service platform bridges the gap between virtual molecule design and real-world manufacturing. Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies Virtually screens compounds from a universe of >60 billion chemical targets and evaluates synthesis routes for safer, cost-effective, higher-yield drug manufacturing Recommends chemicals, reagents […]
Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers Optibrium recently received ISO 27001 accreditation for its information security system CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced that its drug […]
Cambridge, UK – Cresset, an innovative provider of solutions for computer-aided drug design (CADD), design-make-test-analyze (DMTA) efficiency, and drug discovery contract research has been accepted onto the Innovate UK Scaleup Programme, which aims to help specially selected businesses with scaling potential realise their commercial ambitions. From its headquarters in Cambridge, UK, Cresset has ambitious plans to scaleup its […]
Backed by six years’ research, the new StarDrop Metabolism module combines quantum mechanics and machine learning to better predict the metabolic fate of drug candidates The module launches within a larger StarDrop update, which also sees additional features, including high-performance 3D virtual screening capabilities available on desktop CAMBRIDGE, UK – Optibrium, a leading developer of software […]
Cambridge, UK – Torx® Software Limited announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process. Torx, is a cloud-based platform developed by Cresset and Elixir™ Software which enables chemistry teams to collaborate, design molecules and track compound synthesis across the design-make-test-analyze (DMTA) […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
